Literature DB >> 9890374

Loricrin gene mutation in a Japanese patient of Vohwinkel's syndrome.

H Takahashi1, A Ishida-Yamamoto, A Kishi, K Ohara, H Iizuka.   

Abstract

Vohwinkel's syndrome (VS) is a rare, dominantly inherited keratoderma with pseudoainhum. Recently, a mutation in loricrin gene has been reported in two VS families of British extraction. In the present study, we examined the loricrin gene mutation in a Japanese VS patient. The patient was a 20-year-old woman. She had palmoplantar keratoderma, constricting bands encircling all the fingers, fifth toes, wrist, and neck. She also had generalized mild ichthyosis and suffered from acoustic impairment. Her parents and a brother showed no skin abnormality. Histopathology of the patient revealed hyperkeratosis with parakeratosis, together with hypergranulosis. The clinical and histopathological findings were consistent with an ichthyotic (or Camisa) variant of VS. The sequence analysis of the loricrin gene revealed that the patient had a heterozygous mutation identical to that described in previous reports, i.e. a G insertion producing a frameshift at codon 231 with an abnormal C-terminus. These results clearly demonstrate that a common loricrin gene mutation underlies VS in different ethnic groups.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9890374     DOI: 10.1016/s0923-1811(98)00049-8

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  7 in total

Review 1.  Ichthyosis update: towards a function-driven model of pathogenesis of the disorders of cornification and the role of corneocyte proteins in these disorders.

Authors:  Matthias Schmuth; Robert Gruber; Peter M Elias; Mary L Williams
Journal:  Adv Dermatol       Date:  2007

2.  Embryonic AP1 Transcription Factor Deficiency Causes a Collodion Baby-Like Phenotype.

Authors:  Christina A Young; Richard L Eckert; Gautam Adhikary; Debra Crumrine; Peter M Elias; Miroslav Blumenberg; Ellen A Rorke
Journal:  J Invest Dermatol       Date:  2017-05-16       Impact factor: 8.551

3.  Activation of vascular endothelial growth factor receptor 2 in a cellular model of loricrin keratoderma.

Authors:  Kozo Yoneda; Toshio Demitsu; Kozo Nakai; Tetsuya Moriue; Wataru Ogawa; Junsuke Igarashi; Hiroaki Kosaka; Yasuo Kubota
Journal:  J Biol Chem       Date:  2010-03-17       Impact factor: 5.157

4.  Suppressing AP1 factor signaling in the suprabasal epidermis produces a keratoderma phenotype.

Authors:  Ellen A Rorke; Gautam Adhikary; Christina A Young; Dennis R Roop; Richard L Eckert
Journal:  J Invest Dermatol       Date:  2014-08-22       Impact factor: 8.551

5.  Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein.

Authors:  P J Koch; P A de Viragh; E Scharer; D Bundman; M A Longley; J Bickenbach; Y Kawachi; Y Suga; Z Zhou; M Huber; D Hohl; T Kartasova; M Jarnik; A C Steven; D R Roop
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

6.  Transgenic mice expressing a mutant form of loricrin reveal the molecular basis of the skin diseases, Vohwinkel syndrome and progressive symmetric erythrokeratoderma.

Authors:  Y Suga; M Jarnik; P S Attar; M A Longley; D Bundman; A C Steven; P J Koch; D R Roop
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

7.  Novel autosomal dominant mutation in loricrin presenting as prominent ichthyosis.

Authors:  E Pohler; F Cunningham; A Sandilands; C Cole; S Digby; J R McMillan; S Aristodemou; J A McGrath; F J D Smith; W H I McLean; C S Munro; M Zamiri
Journal:  Br J Dermatol       Date:  2015-08-22       Impact factor: 9.302

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.